Form 4: DSS, Inc. Increases Stake in Impact Biomedical Inc.

DSS, Inc., a 10% owner of Impact Biomedical Inc., reports acquiring additional shares of common stock through indirect ownership.

Summary

• DSS, Inc. has filed a Form 4 detailing changes in beneficial ownership of Impact Biomedical Inc. stock.
• On September 16, 2024, DSS, Inc. acquired 50,000 shares of common stock at a price of $2.69 per share through Sentinel Brokers Company, Inc., a majority-owned subsidiary.
• On September 17, 2024, DSS, Inc. acquired 7,800 shares of common stock at a price of $2.4 per share through Sentinel Brokers Company, Inc.
• Following these transactions, DSS, Inc. indirectly owns 57,800 shares through Sentinel Brokers Company, Inc.
• DSS, Inc. also indirectly owns 1,345,482 shares through DSS BioHealth Security, Inc., 166,600 shares through DSS Securities, Inc., and 166,600 shares through DSS BlockChain Security, Inc., all wholly-owned subsidiaries.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it simply reports transactions. The increased stake could be seen as a positive signal, but without further context, it's difficult to assess the overall impact.

Positives

• DSS, Inc.'s increased investment in Impact Biomedical Inc. could signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and major shareholders, providing transparency to the market.

Stakeholder Impact

• The increased stake by DSS, Inc. could be viewed positively by shareholders of Impact Biomedical Inc.

Key Dates